Text messages and chatbots may help catch lung cancer earlier in underserved communities

NCT ID NCT07716280

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether digital tools—text messages, a chatbot, an educational video, and patient navigation—can help more people in low-resource clinics get screened for lung cancer. Participants are current or former smokers aged 50–80 who speak English or Spanish and have a phone that can text. The goal is to see if these strategies increase the number of people who complete lung cancer screening, which could lead to earlier detection and better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
digital health tools including text messages, chatbot, educational video, and patient navigation
What this could lead to
If successful, this approach could increase lung cancer screening rates in underserved communities, catching cancers earlier when they are more treatable.
What could go wrong
This is a small, early-stage implementation study in three clinics, so results may not apply broadly. The digital tools may not overcome all barriers to screening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huntsman Cancer Institute/ University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.